These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Biochemical findings after bone marrow transplantation for metachromatic leukodystrophy: a preliminary report. Ladisch S; Bayever E; Philippart M; Feig SA Birth Defects Orig Artic Ser; 1986; 22(1):69-76. PubMed ID: 3516243 [No Abstract] [Full Text] [Related]
25. Immunologic studies in primates undergoing concordant xenotransplantation as a bridge allotransplantation. Shah AS; Itescu S; O'Hair DP; Tugulea S; Kwiatkowski PA; Liu Z; Platt JL; Rose EA; Suciu-Foca N; Michler RE Transplant Proc; 1996 Apr; 28(2):745-6. PubMed ID: 8623377 [No Abstract] [Full Text] [Related]
26. Erythrocyte-to-plasma distribution ratio of cyclosporine: a useful indicator to predict cyclosporine pharmacokinetics and physiological changes during cyclosporine monitoring. Shibata N; Hoshino N; Yamaji A; Park KI; Inoue H; Tomoyoshi T; Sako H; Abe H; Kodama M; Nakane Y Transplant Proc; 1996 Jun; 28(3):1313-5. PubMed ID: 8658674 [No Abstract] [Full Text] [Related]
27. Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression. Bredius RG; Laan LA; Lankester AC; Poorthuis BJ; van Tol MJ; Egeler RM; Arts WF Bone Marrow Transplant; 2007 Mar; 39(5):309-10. PubMed ID: 17237829 [No Abstract] [Full Text] [Related]
28. Bone marrow transplantation in metachromatic leukodystrophy. Lipton M; Lockman LA; Ramsay NK; Kersey JH; Jacobson RI; Krivit W Birth Defects Orig Artic Ser; 1986; 22(1):57-67. PubMed ID: 2870748 [No Abstract] [Full Text] [Related]
29. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine. Bökenkamp A; Offner G; Hoyer PF; Wonigeit K; Brodehl J Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223 [No Abstract] [Full Text] [Related]
30. New approaches to cyclosporine monitoring raise further concerns about analytical techniques. Holt DW; Johnston A; Kahan BD; Morris RG; Oellerich M; Shaw LM Clin Chem; 2000 Jun; 46(6 Pt 1):872-4. PubMed ID: 10839783 [No Abstract] [Full Text] [Related]
31. Relationship between MDR1 polymorphism and blood concentration of cyclosporine A. Wang W; Zhang XD; Guan DL; Lü YP; Ma LL; Hu XP; Zhang P; Wang Y; Chen X Chin Med J (Engl); 2005 Dec; 118(24):2097-100. PubMed ID: 16438909 [No Abstract] [Full Text] [Related]
32. Analysis of antiporcine antibodies in cynomolgus recipients of porcine kidneys on cyclophosphamide-based immunosuppression. Kunz R; Loss M; Schwinzer R; Rensing S; Kaup J; Klempnauer J; Winkler M Transplant Proc; 2000 Aug; 32(5):866. PubMed ID: 10936249 [No Abstract] [Full Text] [Related]
34. Effect of troglitazone on cyclosporine whole blood levels. Burgess SJ; Singer GG; Brennan DC Transplantation; 1998 Jul; 66(2):272. PubMed ID: 9701278 [No Abstract] [Full Text] [Related]
35. Measurement of lymphocyte cyclosporine levels in transplant patients. Masri MA; Barbari A; Stephan A; Rizk S; Kilany H; Kamel G Transplant Proc; 1998 Nov; 30(7):3561-2. PubMed ID: 9838559 [No Abstract] [Full Text] [Related]
36. [Aseptic thrombosis of the intracranial venous sinuses in a patient with kidney transplantation and toxic levels of cyclosporine]. Guerrero AL; Arcaya J; Cacho J; Seisdedos L Med Clin (Barc); 1999 Feb; 112(6):238-9. PubMed ID: 10191492 [No Abstract] [Full Text] [Related]
37. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group. Gentil Govantes MA; Gómez Ullate P; Errasti P; Fernández Fresnedo G; Capdevila L; Sanz Guajardo A; Cubero JJ Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231 [No Abstract] [Full Text] [Related]
38. [Program of external quality control in cyclosporine dosage: summary and analysis from French laboratories]. Marquet P; Perrin A; Billaud E; Méninat F; Johnston A; Holt DW; Vassault A Ann Biol Clin (Paris); 1999 May; 57(3):360-3. PubMed ID: 10377491 [No Abstract] [Full Text] [Related]
39. Gene therapy in metachromatic leukodystrophy. Sevin C; Cartier-Lacave N; Aubourg P Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324 [TBL] [Abstract][Full Text] [Related]
40. Infantile metachromatic leukodystrophy in an 18 month old girl. Ali Mallick MS; Godil A; Khetpal A; Rizvi AH; Khan F J Pak Med Assoc; 2016 Sep; 66(9):1197-1200. PubMed ID: 27654749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]